- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Nucleic Acids
Volume 2012 (2012), Article ID 283560, 10 pages
Expression Profiling of a Heterogeneous Population of ncRNAs Employing a Mixed DNA/LNA Microarray
1Section for Genomics and RNomics, Biocenter, Innsbruck Medical University, Fritz Pregl Strasse 3, 6020 Innsbruck, Austria
2Institute for Genomics and Bioinformatics, Graz University of Technology, Petersgasse 14, 8010 Graz, Austria
3Université de Lorraine, CNRS-UMR 7214 AREMS, 9 avenue de la Forêt de Haye, F-54506 Vandoeuvre-lès-Nancy, France
Received 30 November 2011; Revised 6 March 2012; Accepted 6 March 2012
Academic Editor: Ashis K. Basu
Copyright © 2012 Konstantinia Skreka et al.
Mammalian transcriptomes mainly consist of non protein coding RNAs. These ncRNAs play various roles in all cells and are involved in multiple regulation pathways. More recently, ncRNAs have also been described as valuable diagnostic tools. While RNA-seq approaches progressively replace microarray-based technologies for high-throughput expression profiling, they are still not routinely used in diagnostic. Microarrays, on the other hand, are more widely used for diagnostic profiling, especially for very small ncRNA (e.g., miRNAs), employing locked nucleic acid (LNA) arrays. However, LNA microarrays are quite expensive for high-throughput studies targeting longer ncRNAs, while DNA arrays do not provide satisfying results for the analysis of small RNAs. Here, we describe a mixed DNA/LNA microarray platform, where directly labeled small and longer ncRNAs are hybridized on LNA probes or custom DNA probes, respectively, enabling sensitive and specific analysis of a complex RNA population on a unique array in one single experiment. The DNA/LNA system, requiring relatively low amounts of total RNA, which complies with diagnostic references, was successfully applied to the analysis of differential ncRNA expression in mouse embryonic stem cells and adult brain cells.
The high-resolution analysis of 1% of the human genome by the ENCODE project has shown that up to 90% of the genome is being transcribed while only about 1.5% of these transcripts correspond to protein coding exons . Therefore, it was suggested that the majority of the transcripts might serve as a source for regulatory non coding RNAs (ncRNAs) [2, 3], with the predicted number of ncRNAs present in the human genome reaching up to 0.5 million transcripts . However, most of these transcripts still remain of unknown function, and their functionality is even debated .
These novel exciting aspects of the cellular transcriptome content thus require novel methods for profiling ncRNAs expression in a high-throughput manner. Lately, the most widely used expression profiling technique has become high-throughput sequencing or RNA-seq [5, 6], with numerous advantages. RNA-seq provides full genome coverage and allows detection of single nucleotide polymorphisms as well as RNA editing events, independently of hybridization artifacts. However, RNA-seq drawbacks and artifacts are not completely absent, generally linked to reverse transcription or library generation protocols [6, 7]. In addition, analysis of sequencing datasets is still rather time consuming and requires a strong bioinformatic expertise, which does not make it suitable for rapid diagnostic or clinical profiling so far. An alternative high-throughput approach is based on microarrays. Recently, novel microarray technologies have evolved to efficiently profile miRNA expression [8, 9] or detect single nucleotide polymorphisms  by employing locked nucleic acid (LNA) arrays. LNAs are synthetic RNA analogs characterized by increased thermostability of nucleic acid duplexes, allowing increased hybridization temperatures and thus improved mismatch discrimination . With the recent interest in ncRNAs as biomarkers [12–14], ncRNA microarrays might represent a suitable tool to profile ncRNA expression for diagnostic purposes. However, an LNA platform would not be generally financially affordable for these applications. Here, we describe a mixed DNA/LNA microarray platform that allows the hybridization of directly and simultaneously labeled small and longer ncRNAs onto microarrays consisting of both LNA-modified and custom-designed DNA capture probes, respectively. This method enables a sensitive and specific analysis of a complex and heterogeneous RNA population on a unique array in one experiment, complying with nowadays most criteria in biomedical diagnostics in terms of cost and sample requirements.
2. Materials and Methods
The miRCURY LNA miRNA array ready-to-spot probe set (reference 208010) was purchased from Exiqon (Denmark) as an LNA capture probe set for short ncRNAs detection. This set comprises 2,056 capture probes designed to have a uniform of 72°C and covers all miRNAs of miRBase (version 9.2).
The DNA probes were purchased from Microsynth (Switzerland). They were 5′-C6 amino-modified, designed so as to comply with a 72°C , desalted and diluted in 3xSSC, 1.5 M Betaine buffer to a final concentration of 20 μM.
2.2. ncRNA Chip
The LNA-based capture probe set for short ncRNAs as well as the self-designed DNA-based capture probe set for long ncRNAs was spotted on HiSens epoxy-coated glass slides (Nexterion) using the MicroGrid II Microarray Spotter (Zinsser Analytic). Every probe (antisense, mismatch, deletion, and sense) was spotted twice on the slide in four replicates (local separation) to ensure quality assurance and reliability.
2.3. Hybridization Station
Hybridizations have been performed using the Tecan HS400 hybridization station according to the Exiqon protocol for hybridization with the miRNA LNA platform. Hybridizations were performed at 56°C or 64°C.
2.4. Microarray Scanner
The ncRNA chip was scanned using the Axon instruments GenePix 4000B.
2.5. RNA Labeling
Total mouse brain RNA was extracted from C57/Bl6 mice (4–8 weeks old) and total mouse embryonic stem cell RNA from E14 stem cells with TriReagent (Sigma-Aldrich) following the manufacturer's protocol. RNA was quantified employing a nanodrop spectrophotometer (Fischer Scientific). Total mouse brain RNA (0.25 μg–5 μg) and total mouse embryonic stem cell RNA (2 μg) were directly labeled employing the NCode Rapid miRNA Labeling System (Invitrogen), following the manufacturer’s protocol with the following modifications: (i) prior to poly-A tailing, RNA was denatured at 90°C for 3 min, centrifuged, and cooled on ice for 2 min and (ii) the reaction buffer provided with the kit was replaced by a custom reaction buffer containing 50 mM Tris-HCl (pH 8.0), 250 mM NaCl, and 10 mM MgCl2. For differential expression, 2 biological replicates of total mouse brain RNA and total mouse embryonic stem cell RNA were used.
2.6. Probe Design
Probes were designed employing OligoWiz. Post-processing steps, including verification of probes specificity or processing events coverage, were added. For a full description, see .
2.7. Northern Blot
Northern blots were performed as described previously . Following oligonucleotides (Sigma-Aldrich) were used: SNORA71 5′-TATCAATGACCAGGGCACCCGCAGCCC-3′, SNORD55 5′-GTCGGGAGTGTGCAGCATACCCAGGTG-3′ and 5′-GCAATTCACATTAATTCTCGCAGCTAGC-3′.
2.8. Real-Time PCR
Total RNA was isolated from mouse ES cells and mouse brain of C57/Bl6 mice, 4–6 weeks old, with TRI Reagent (Sigma-Aldrich, Vienna, Austria) according to the manufacturer’s protocol. Five hundred nanograms of total RNA were poly-A tailed and reverse transcribed to cDNA using the microRNA 1st strand synthesis kit (Agilent Technologies, Böblingen, Germany) following the manufacturer’s protocol.
The cDNA was used as template for the real-time PCR. The universal reverse primer provided with the kit was used together with the following forward primers: mmu-miR-125-5p 5′-TCCCTGAGACCCTAACTTGTGA-3′, mmu-miR-293 5′-AGTGCCGCAGAGTTTG-TAGTGT-3′, SNORD113 5′-GGGTGCTGTATGAGTCGTGTATTATGA-3′, 7SK 5′-CCATTGTAGGAGAACGTAGGGTAG-3′, SNOZ39 5′-TGATGAAGCAAATCAGTATGAATAAAATG-3′, SNORA18 5′-TGACTCACAGGACTGACTGTTAGGCCTG-3′, SNORD55 5′-CACCTGGGTATGCTGCACACTCC-3′, SNORA71 5′-CTGCCGGTGCCCTGGTCATTG-3′, U6 5′-CTCGCTTCGGCAGCACA-3′.
Primers were purchased from Sigma-Aldrich. Real-time PCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems, Darmstadt, Germany). Reactions were performed for 40 cycles with annealing step temperature set at 60°C. All results from three technical replicates were normalized to U6 and expressed as ΔCt values. Relative expression ratios were calculated by the ΔΔCt method . Five independent biological samples from either mouse brain or mouse ES cells contributed to the data set. Data are presented as mean ± standard error of the mean (SEM). Student t-test was applied to compare between two groups. Differences were considered significant when .
3. Results and Discussion
3.1. Development of a Mixed DNA/LNA Microarray
We investigated whether a combined DNA and LNA platform, dedicated to the expression analysis of long ncRNAs as well as small ncRNAs, respectively, could be used for the expression profiling of a heterogeneous population of ncRNAs. To that end, we generated a custom microarray spotted with (i) DNA capture probes for tRNAs, 7SK RNA as well as C/D and H/ACA box snoRNAs (Supplementary Table 1) and (ii) the commercially available miRCURY LNA miRNA ready-to-spot probe set from Exiqon. To generate a mixed DNA/LNA microarray, all probes spotted had to exhibit the same melting temperature. We opted for a fixed hybridization temperature to avoid elevated background due to unspecific hybridization, as observed when using temperature gradients  (see the Supplementary Material available online at http://dx.doi.org/10.1155/2012/283560). As the LNA capture probe set melting temperature corresponds to 72°C for an optimal hybridization temperature of 64°C, DNA capture probes were designed to comply with this criterion, independently of their sizes. DNA capture probes were designed to hybridize to conserved regions of ncRNAs, spanning regions of 30 to 60 nt (see Section 2). 7SK RNA and tRNAs were chosen to test hybridization capabilities for highly structured ncRNAs and snoRNAs to check for the system sensitivity. Two or more DNA capture probes were designed per ncRNA if the length of the target was sufficient (Supplementary Table 1). Additionally, in order to test the specificity of the system, probes bearing one or two nucleotides mismatches were designed in addition to the perfect matching antisense probes. Finally, for more structured ncRNAs, probes with one or two nucleotides deletions were designed (Supplementary Table 1). Sense probes for each ncRNA and random DNA probes were included as negative controls.
3.2. Direct RNA Labeling
The choice of the RNA labeling method had to be addressed. Indeed, for microarray assays, small RNAs are generally directly labeled while longer RNAs are generally reverse transcribed into cDNA and labeled through incorporation of aminoallyl-modified nucleotides. We employed a commercially available dual fluorescent dye RNA labeling kit based on poly-A tailing and ligation of fluorophore-bearing dendrimers (see Section 2). We used 5 μg total mouse brain RNA for our initial proof of concept experiments. To exclude dye bias effects , AlexaFluor3 and AlexaFluor5 labeled total mouse brain RNA replicas were self-self hybridized on the custom DNA/LNA chip. Analysis of the results showed that neural miRNAs such as miR-9 and miR-9* were well detected (Figure 1(a)) in contrast to snoRNAs which were almost undetectable (Figure 1(b)). 7SK RNA was only marginally detectable (Supplementary Figure 1(a)) while tRNAs were almost not detectable at all. As insufficient detection of these longer ncRNAs could be linked to secondary structure-related inefficient polyadenylation and labeling, we introduced a denaturation step prior to poly-A tailing. Additionally, as Mn2+ cations were reported to stimulate unspecific activity of poly-A polymerase activity in vitro , we tested a Mg2+ custom poly-A tailing buffer (see Section 2), which increased efficiency of labeling, most likely by stimulating polyadenylation. The improved labeling protocol enabled enhanced snoRNAs, tRNAs, and 7SK RNA detection (cf. Figures 1(d) and 1(b), cf. Supplementary Figures 1(b) and 1(a), Figures 2(a) and 2(b) and Supplementary Figure 1(c)) without altering detection of miRNAs (cf. Figures 1(a) and 1(c)). Finally, posttranscriptional RNA modifications , such as pseudouridylation or 2′O-methylation [22, 23], might interfere with labeling of ncRNAs; we did not investigate, however, the extent of this parameter.
3.3. Optimization of RNA Quantity and Hybridization Temperature
Together with RNA labeling it was also necessary to optimize RNA quantity used for labeling. As few as 30 ng total RNA are generally sufficient for hybridization on LNA microarrays, while DNA microarrays require at least 10–25 μg of total RNA as starting material for cDNA labeling through reverse transcription. Amounts of total RNA ranging from 0.25 to 1 μg per labeling reaction were used, with a first hybridization temperature of 56°C. Under these conditions, labeling of total RNA quantities below 1 μg provided insufficient results (data not shown) while labeling of 1 μg of RNA resulted in satisfying results (Figures 2(a) and 2(b)). Next, the hybridization temperature was raised to 64°C to better comply with the LNA platform. In order not to compromise the sensitivity at this temperature, the quantity of labeled total RNA was raised from 1 μg to 2 μg. In these conditions, we observed similar results regarding miRNA LNA probes, but improved detection in the case of the 7SK RNA and snoRNAs (Figures 3(a) and 3(b)). We generally observed improved detection at 64°C for the DNA probes compared to the 56°C condition, while LNA probes remained unaffected (Figure 3(b)). However, as for tissue profiling, large quantities of total RNA might not be available, we opted for 2 μg of total RNA per labeling reaction, with self-self hybridizations performed at 64°C, which appeared as the best compromise. For diagnostic purposes with lower amounts of material, further optimization of the protocol might be needed.
3.4. Sensitivity and Specificity of the Mixed DNA/LNA Microarray
We next tested the influence of ncRNA structure on the sensitivity and specificity of hybridization on the DNA/LNA combined platform. At 56°C, expression of highly structured RNAs, such as tRNAs and 7SK RNA, could be detected (Figures 2(a) and 2(b)). For example, tRNAPhe was detected with a mean intensity of 7555 with the 60 nt long capture probe tRNAPhe_16-75, but with a reduced mean intensity of 1564 with the 30 nt long probe tRNAPhe_47-76 (Figure 2(c)). On the other hand, detection of 7SK RNA was almost 2-fold higher with the 36 nt long capture probe 7SK_126-162 compared to the probes 7SK_17–63 and 7SK_55–91 of 46 and 36 nucleotides in length, respectively, (Figure 2(c)). Thus, detection of highly structured ncRNAs appears rather independent of the capture probe’s length, and employing multiple probes complementary to one particular RNA therefore increases sensitivity of detection.
At 64°C, the results showed that antisense snoRNA capture probes detected efficiently snoRNAs (Figure 4(a)) with similar intensities compared to the condition where higher amounts of labeled total RNA and lower hybridization temperatures were employed (Figure 1(d)). Moreover, almost all antisense snoRNA capture probes detected their specific snoRNA but with different intensities (Figure 4(b)), while the detection levels of miR-9 and miR-9* remained identical (Figure 4(c)).
Discrimination at the nucleotide scale is possible with LNA capture probes. Therefore, we wanted to test how specific the detection with DNA capture probes can be with the DNA/LNA platform. The specificity was therefore checked employing also probes with mismatches at one (MM1) or two (MM2) positions. At 64°C, the snoRNA SNOZ39 was only detected by the antisense and one nucleotide mismatch capture probes, while the signal with the two nucleotides mismatch probe SNOZ39_6-60MM2 was falling below threshold (Figure 5(a)), indicating that discrimination was already possible with two nucleotides mismatches. However, the comparison of the mean intensity values between the perfect matching and one nucleotide mismatch probes showed a reduction of 40% for the MM1 probe for detection of SNOZ39 (Figure 5(b)). In some cases though, a signal was still detectable with MM2 probes (7SK RNA or snoRNA SNORD55, Figure 5(c)), but with reduced intensities compared to the perfect matching capture probes. For instance, 7SK_17–63MM2 and 7SK_55–91MM2 showed a further 20% reduction in intensity levels compared to the MM1 capture probes (Figure 5(c)).
3.5. DNA/LNA Platform Accuracy for Expression Profiling
We next applied our DNA/LNA platform to expression profiling, employing dye swap experiments with 2 μg of total mouse brain RNA and 2 μg of total mouse embryonic stem cells RNA. Hybridizations were performed at 64°C. As expected, differences in ncRNA expression between mouse adult brain RNA and mouse embryonic stem cell RNA could be detected (Figure 6). For example, stem cell specific miRNAs of the miR-290 family (miR-291–295, ) were detected to be about 25-fold overexpressed in mouse embryonic stem cells, while brain-specific miR-124 and miR-9 were about 14-fold overexpressed in mouse brain (Supplementary Table 2). Additionally, the brain-enriched miR-125b-5p was also about 13.5-fold overexpressed. Also let-7 was overexpressed in brain compared to ES cells, which was expected, since mature let-7 is expressed upon stem cell differentiation into neural cells (data not shown) [25, 26]. Regarding DNA probes, overexpression of SNORD55 by about 2-fold and SNORA71 by about 5-fold in mouse embryonic stem cells (Figure 6 and Supplementary Table 2) could be observed. This differential expression was confirmed by northern blots (Figure 6(b)) where SNORD55 and SNORA71 appear overexpressed in embryonic stem cells in comparison to mouse brain.
We employed real-time PCR to verify the differential expression observed and validate the DNA/LNA platform. We analyzed both microRNAs and ncRNAs captured by DNA probes for verification. As expected from the microarray data, we verified that miR-125b-5p and miR-293 were significantly overexpressed in mouse brain and mouse ES cells, by 20.7-fold and 6.5-fold, respectively (Figure 7). The snoRNAs SNORA71 and SNORD55 were verified to be significantly overexpressed in mouse ES cells in comparison to mouse brain as well, by 3.3- and 2.5-fold, respectively (Figure 7). According to the DNA/LNA microarray platform data, we did not observe any differential expression for SNORD113 or 7SK RNA between mouse ES cells and mouse brain (Figure 7). Finally, while they did not appear to be differentially expressed in the microarray data, SNORA18 and SNOZ39 seemed to be overexpressed in mouse ES cells or in mouse brain, respectively, according to real-time PCR results (Figure 7). While this differential expression was not significant for SNORA18, it reached 3.6-fold for SNOZ39, highlighting the necessity to validate microarray data, as well as deep-sequencing data, by additional means like northern blotting or real-time PCR. Nevertheless, our observation of differential expression of canonical snoRNAs constitutes an exciting aspect, especially regarding their recently described noncanonical functions as miRNA precursors or regulators of alternative splicing [27–31].
NcRNAs are now widely considered as excellent disease biomarkers . For instance, miRNAs [14, 33], snoRNAs  or long interspersed noncoding RNAs (lincRNAs)  can be employed to determine the origin of various cancers. Noncoding RNAs have also been shown to be involved in chromatin regulation  or in neurological diseases [36, 37]. For diagnostic purposes, microarrays still appear as a less expensive method compared to high-throughput sequencing and, additionally, microarray analysis requires significantly less time. However, a microarray platform enabling simultaneous analysis of both small and long molecules for ncRNA-based diagnostic or expression profiling was lacking. Here we developed a microarray platform where both small and long ncRNAs can be profiled on the same chip. The size limitation of small RNAs prompted us to employ the already available LNA platform for miRNAs, to combine it with custom DNA capture probes for longer ncRNAs and to allow detection of all ncRNAs with a universal direct labeling procedure. Hence, long, structured ncRNAs and miRNAs could be detected with the DNA/LNA platform, and this detection was independent of the capture probe length but rather depending on secondary structure. We observed that capture probes were more efficient when designed to hybridize to less structured regions. In case of highly structured tRNAs, capture probes spanning almost the entire molecule appeared to be the most efficient. The mixed microarray is sensitive and specific and requires relatively low amounts of directly labeled total RNA. Problems due to ncRNA structure can be solved if probes are designed to span low structured regions and if a denaturation step is introduced prior to RNA direct labeling. Hence, this platform might become a very attractive tool for combined expression profiling of small and long ncRNAs as well as in biomedical diagnostic.
The authors are thankful to Irina-Roxana Nat and Georg Dechant for kindly providing mouse embryonic stem cells for RNA extraction. This work was supported by GEN-AU, the Austrian Genome Research (GEN-AU) funding program (Grant “non-coding RNAs” no. 820982). K. Skreka. was supported by an FWF Grand, project no. 2F012060-03 to A. H. La Région Lorraine and the Lorraine University are acknowledged for open access fee payment.
- E. Birney, J. A. Stamatoyannopoulos, A. Dutta et al., “Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project,” Nature, vol. 447, no. 7146, pp. 799–816, 2007.
- J. S. Mattick and I. V. Makunin, “Small regulatory RNAs in mammals,” Human Molecular Genetics, vol. 14, no. 1, pp. R121–R132, 2005.
- J. S. Mattick and I. V. Makunin, “Non-coding RNA,” Human Molecular Genetics, vol. 15, pp. R17–R29, 2006.
- A. T. Willingham and T. R. Gingeras, “TUF Love for “Junk” DNA,” Cell, vol. 125, no. 7, pp. 1215–1220, 2006.
- A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, and B. Wold, “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nature Methods, vol. 5, no. 7, pp. 621–628, 2008.
- A. Saxena and P. Carninci, “Whole transcriptome analysis: what are we still missing?” Wiley Interdisciplinary Reviews, vol. 3, no. 5, pp. 527–543, 2011.
- C. A. Raabe, C. H. Hoe, G. Randau, J. Brosius, T. H. Tang, and T. S. Rozhdestvensky, “The rocks and shallows of deep RNA sequencing: examples in the Vibrio cholerae RNome,” RNA, vol. 17, no. 7, pp. 1357–1366, 2011.
- M. Castoldi, S. Schmidt, V. Benes, M. W. Hentze, and M. U. Muckenthaler, “miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes,” Nature Protocols, vol. 3, no. 2, pp. 321–329, 2008.
- M. Hackl, S. Brunner, K. Fortschegger et al., “miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging,” Aging Cell, vol. 9, no. 2, pp. 291–296, 2010.
- N. Jacobsen, J. Bentzen, M. Meldgaard et al., “LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E.,” Nucleic Acids Research, vol. 30, no. 19, article e100, 2002.
- R. N. Veedu and J. Wengel, “Locked nucleic acids: promising nucleic acid analogs for therapeutic applications,” Chemistry and Biodiversity, vol. 7, no. 3, pp. 536–542, 2010.
- J. Liao, L. Yu, Y. Mei et al., “Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer,” Molecular Cancer, vol. 9, article 198, 2010.
- X. Liu, K. Fortin, and Z. Mourelatos, “MicroRNAs: biogenesis and molecular functions,” Brain Pathology, vol. 18, no. 1, pp. 113–121, 2008.
- N. Rosenfeld, R. Aharonov, E. Meiri et al., “MicroRNAs accurately identify cancer tissue origin,” Nature Biotechnology, vol. 26, no. 4, pp. 462–469, 2008.
- K. Skreka, M. Karbiener, M. Zywicki, H. Alexander, S. Marcel, and R. Mathieu, “Expression profiling of ncRNAs employing RNP libraries and custom LNA/DNA microarray analysis,” Regulatory RNAs: Basics, Methods and Applications, Springer, 2012.
- M. Rederstorff, S. H. Bernhart, A. Tanzer et al., “RNPomics: defining the ncRNA transcriptome by cDNA library generation from ribonucleo-protein particles.,” Nucleic Acids Research, vol. 38, no. 10, article e113, 2010.
- M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, article e45, 2001.
- R. Hutzinger, J. Mrázek, S. Vorwerk, and A. Hüttenhofer, “NcRNA-microchip analysis: a novel approach to identify differential expression of non-coding RNAs,” RNA Biology, vol. 7, no. 5, pp. 586–595, 2010.
- H. Fang, X. Fan, L. Guo et al., “Self-self hybridization as an alternative experiment design to dye swap for two-color microarrays,” OMICS A Journal of Integrative Biology, vol. 11, no. 1, pp. 14–24, 2007.
- J. Lingner, I. Radtke, E. Wahle, and W. Keller, “Purification and characterization of poly(A) polymerase from Saccharomyces cerevisiae,” The Journal of Biological Chemistry, vol. 266, no. 14, pp. 8741–8746, 1991.
- W. A. Cantara, P. F. Crain, J. Rozenski et al., “The RNA modification database, RNAMDB: 2011 update,” Nucleic Acids Research, vol. 39, no. 1, pp. D195–D201, 2011.
- I. Behm-Ansmant, M. Helm, and Y. Motorin, “Use of specific chemical reagents for detection of modified nucleotides in RNA,” Journal of Nucleic Acids, vol. 2011, Article ID 408053, 17 pages, 2011.
- R. Ishitani, S. Yokoyama, and O. Nureki, “Structure, dynamics, and function of RNA modification enzymes,” Current Opinion in Structural Biology, vol. 18, no. 3, pp. 330–339, 2008.
- Y. Wang and R. Blelloch, “Cell cycle regulation by microRNAs in stem cells,” Results Probl Cell Differ, vol. 53, pp. 459–472, 2010.
- A. Rybak, H. Fuchs, L. Smirnova et al., “A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment,” Nature Cell Biology, vol. 10, no. 8, pp. 987–993, 2008.
- F. G. Wulczyn, L. Smirnova, A. Rybak et al., “Post-transcriptional regulation of the let-7 microRNA during neural cell specification,” The FASEB Journal, vol. 21, no. 2, pp. 415–426, 2007.
- C. Ender, A. Krek, M. R. Friedländer et al., “A Human snoRNA with MicroRNA-Like Functions,” Molecular Cell, vol. 32, no. 4, pp. 519–528, 2008.
- S. Kishore, A. Khanna, Z. Zhang et al., “The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing,” Human Molecular Genetics, vol. 19, no. 7, Article ID ddp585, pp. 1153–1164, 2010.
- S. Kishore and S. Stamm, “The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C,” Science, vol. 311, no. 5758, pp. 230–232, 2006.
- A. A. Saraiya and C. C. Wang, “snoRNA, a novel precursor of microRNA in Giardia lamblia,” PLoS Pathogens, vol. 4, no. 11, Article ID e1000224, 2008.
- R. J. Taft, E. A. Glazov, T. Lassmann, Y. Hayashizaki, P. Carninci, and J. S. Mattick, “Small RNAs derived from snoRNAs,” RNA, vol. 15, no. 7, pp. 1233–1240, 2009.
- S. Gilad, E. Meiri, Y. Yogev et al., “Serum microRNAs are promising novel biomarkers,” PLoS One, vol. 3, no. 9, Article ID e3148, 2008.
- J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005.
- R. A. Gupta, N. Shah, K. C. Wang et al., “Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis,” Nature, vol. 464, no. 7291, pp. 1071–1076, 2010.
- M. Huarte and J. L. Rinn, “Large non-coding RNAs: missing links in cancer?” Human Molecular Genetics, vol. 19, no. 2, pp. R152–R161, 2010.
- J. Kocerha, S. Kauppinen, and C. Wahlestedt, “microRNAs in CNS disorders,” Neuromolecular Medicine, vol. 11, no. 3, pp. 162–172, 2009.
- M. Rederstorff and A. Hüttenhofer, “Small non-coding RNAs in disease development and host-pathogen interactions,” Current Opinion in Molecular Therapeutics, vol. 12, no. 6, pp. 684–694, 2010.